Grant Theron
Grant Theron
Professor, Biomedical Sciences and Human Genetics, CLIME group PI, Stellenbosch University
Verified email at - Homepage
Cited by
Cited by
The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis
K Dheda, T Gumbo, G Maartens, KE Dooley, R McNerney, M Murray, ...
The lancet Respiratory medicine 5 (4), 291-360, 2017
Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial
G Theron, L Zijenah, D Chanda, P Clowes, A Rachow, M Lesosky, W Bara, ...
The Lancet 383 (9915), 424-435, 2014
Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting
G Theron, J Peter, R van Zyl-Smit, H Mishra, E Streicher, S Murray, ...
American journal of respiratory and critical care medicine 184 (1), 132-40, 2011
Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis
K Dheda, T Gumbo, NR Gandhi, M Murray, G Theron, Z Udwadia, ...
The lancet Respiratory medicine 2 (4), 321-338, 2014
Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic …
JG Peter, LS Zijenah, D Chanda, P Clowes, M Lesosky, P Gina, N Mehta, ...
The Lancet 387 (10024), 1187-1197, 2016
What is the cost of diagnosis and management of drug resistant tuberculosis in South Africa?
A Pooran, E Pieterson, M Davids, G Theron, K Dheda
PloS one 8 (1), e54587, 2013
Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous meningitis in a high burden setting: a prospective study
VB Patel, G Theron, L Lenders, B Matinyena, C Connolly, R Singh, ...
PLoS medicine 10 (10), e1001536, 2013
The South African tuberculosis care cascade: estimated losses and methodological challenges
P Naidoo, G Theron, MX Rangaka, VN Chihota, L Vaughan, ZO Brey, ...
The Journal of infectious diseases 216 (suppl_7), S702-S713, 2017
Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings?
G Theron, J Peter, D Dowdy, I Langley, SB Squire, K Dheda
The Lancet infectious diseases 14 (6), 527-532, 2014
Point‐of‐care diagnosis of tuberculosis: Past, present and future
K Dheda, M Ruhwald, G Theron, J Peter, WC Yam
Respirology 18 (2), 217-232, 2013
Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients
JG Peter, G Theron, R van Zyl-Smit, A Haripersad, L Mottay, S Kraus, ...
European respiratory journal 40 (5), 1211-1220, 2012
The diagnostic accuracy of the GenoTypeŽ MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs
G Theron, J Peter, M Richardson, M Barnard, S Donegan, R Warren, ...
The Cochrane database of systematic reviews, 4, 2014
Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable …
K Dheda, JD Limberis, E Pietersen, J Phelan, A Esmail, M Lesosky, ...
The lancet Respiratory medicine 5 (4), 269-281, 2017
Xpert MTB/RIF results in patients with previous tuberculosis: can we distinguish true from false positive results?
G Theron, R Venter, G Calligaro, L Smith, J Limberis, R Meldau, ...
Clinical Infectious Diseases 62 (8), 995-1001, 2016
Accuracy and impact of Xpert MTB/RIF for the diagnosis of smear-negative or sputum-scarce tuberculosis using bronchoalveolar lavage fluid
G Theron, J Peter, R Meldau, H Khalfey, P Gina, B Matinyena, L Lenders, ...
Thorax 68 (11), 1043-1051, 2013
Determinants of PCR performance (Xpert MTB/RIF), including bacterial load and inhibition, for TB diagnosis using specimens from different body compartments
G Theron, J Peter, G Calligaro, R Meldau, C Hanrahan, H Khalfey, ...
Scientific reports 4 (1), 1-10, 2014
Data for action: collection and use of local data to end tuberculosis
G Theron, HE Jenkins, F Cobelens, I Abubakar, AJ Khan, T Cohen, ...
The Lancet 386 (10010), 2324-2333, 2015
Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South Africa
K Shean, E Streicher, E Pieterson, G Symons, R van Zyl Smit, G Theron, ...
PloS one 8 (5), e63057, 2013
The Diagnostic Accuracy of Urine-Based Xpert MTB/RIF in HIV-Infected Hospitalized Patients Who Are Smear-Negative or Sputum Scarce
JG Peter, G Theron, TE Muchinga, U Govender, K Dheda
PLoS ONE 7 (7), e39966, 2012
Comparison of quantitative techniques including Xpert MTB/RIF to evaluate mycobacterial burden
RN van Zyl-Smit, A Binder, R Meldau, H Mishra, PL Semple, G Theron, ...
PloS one 6 (12), e28815, 2011
The system can't perform the operation now. Try again later.
Articles 1–20